New Prostate Cancer Pill Gives Extra Life
A research has revealed a pill for men with prostate cancer, who have exhausted all alternative that gives four months extra life. The drug also reduces the pain experienced by most of them, it’s known by its brand name of Zytiga, and was discovered by British scientists at the Institute of Cancer Research.
In the research trial, men given abiraterone acetate and a steroid survived for nearly 15 months, while those given only steroid treatment and a 'dummy' pill survived for an average of 11 months along with side effects of fluid retention and swelling.
The drug is directed at prolonging the life of prostate cancer victims, by combining new and older agents. It can be used in about 80% of patients with aggressive drug resistant prostate cancer who have undergone arrays of antihormonal therapies and chemotherapies
However, Professor Johann de Bono from the ICR and The Royal Marsden, chief trial investigator and lead author, has expressed that he was excited that the Institute of Cancer Research had discovered a drug that is proven to crucially extend the life of many men, as well as give doctors a substantial new treatment alternative.
New Zealand News
- Tesla to design & build affordable EV in China: Tom Zhu
- First deliveries of all-electric Porsche in Australia to take place this weekend
- Crown Resorts suffers record six-month loss due to COVID-19 closures
- Australia’s Crown Resorts 'not suitable' for Sydney gaming license: Inquiry Commission
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?